methamphetamine has been researched along with Disease Exacerbation in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (27.27) | 29.6817 |
| 2010's | 14 (63.64) | 24.3611 |
| 2020's | 2 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Agarwal, K; Cherian, KE; Kapoor, N; Paul, TV | 1 |
| Aeddula, NR; Baradhi, KM; Bose, S; Pathireddy, S | 1 |
| Adler, E; Bhatia, HS; Dickson, S; Greenberg, B; Nishimura, M; Thomas, IC | 1 |
| Carrico, AW; Cherenack, EM; Dilworth, SE; Hunt, P; Oni, O; Pahwa, S; Pallikkuth, S; Riley, ED; Roach, ME; Roy, S; Shoptaw, S | 1 |
| Aouizerat, BE; Carrico, AW; Dilworth, SE; Flentje, A; Flowers, E; Hunt, P; Kober, K; Lee, S; Pahwa, S; Riley, ED; Shoptaw, S | 1 |
| Carrico, AW; Dilworth, SE; Grosgebauer, K; Koru-Sengul, T; Pahwa, S; Pallikkuth, S; Roach, M; Salinas, J; Sharkey, M; Stevenson, M | 1 |
| Addison, M; Gilvarry, E; Kaner, E; Martens, MS; McGovern, R; O'Donnell, A; Rosenkranz, M; Spencer, L; Verthein, U; Zurhold, H | 1 |
| Bowyer, JF; Faubion, MG; Hanig, JP; Robinson, BL; Sarkar, S; Tranter, KM | 1 |
| Albertson, M; Groskreutz, D; Jamous, F | 1 |
| Dash, C; Pandhare, J; Passaro, RC; Qian, HZ | 1 |
| Dietze, P; Horyniak, D; O'Keefe, D | 1 |
| Shaw, D; Sliman, S; Waalen, J | 1 |
| Aungier, J; Morton, AJ; Ouk, K | 1 |
| Gácser, A; Martinez, LR; Mihu, MR; Nosanchuk, JD; Santambrogio, L | 1 |
| Gentry, WB; Owens, SM; Rüedi-Bettschen, D | 1 |
| Cisneros, IE; Ghorpade, A | 1 |
| Nair, MP; Samikkannu, T | 1 |
| Card, JP; Hastings, TG; LaVoie, MJ | 1 |
| Chen, JP | 1 |
| Barrington, EH; Gonzalez Castro, F; Rawson, RA; Walton, MA | 1 |
| Avison, MJ; Berger, JR; Maragos, WF; Nath, A; Schmitt, FA | 1 |
| Hickey, MA; Morton, AJ; Reynolds, GP | 1 |
5 review(s) available for methamphetamine and Disease Exacerbation
| Article | Year |
|---|---|
Which individual, social and environmental influences shape key phases in the amphetamine type stimulant use trajectory? A systematic narrative review and thematic synthesis of the qualitative literature.
Topics: Amphetamine-Related Disorders; Disease Progression; Humans; Methamphetamine; Motivation; N-Methyl-3,4-methylenedioxyamphetamine; Peer Group; Qualitative Research; Risk Factors; Sexual Behavior; Social Behavior; Social Environment | 2019 |
The Complex Interaction Between Methamphetamine Abuse and HIV-1 Pathogenesis.
Topics: Amphetamine-Related Disorders; Animals; CD4-Positive T-Lymphocytes; Disease Progression; HIV Infections; HIV-1; Humans; Methamphetamine | 2015 |
HIV-1, methamphetamine and astrocyte glutamate regulation: combined excitotoxic implications for neuro-AIDS.
Topics: Acquired Immunodeficiency Syndrome; AIDS Dementia Complex; Amino Acid Transport System X-AG; Astrocytes; Blood-Brain Barrier; Central Nervous System Stimulants; Disease Progression; Excitatory Amino Acid Transporter 2; Female; Gene Expression Regulation; Glutamic Acid; Humans; Male; Methamphetamine; Neurotransmitter Agents; Substance Abuse, Intravenous | 2012 |
Differential regulation of neurotoxin in HIV clades: role of cocaine and methamphetamine.
Topics: Acquired Immunodeficiency Syndrome; AIDS Dementia Complex; Arachidonic Acid; Central Nervous System Stimulants; Cocaine; Cyclooxygenase 2; Disease Progression; Female; HIV Envelope Protein gp120; HIV-1; Humans; Male; Methamphetamine; Quinolinic Acid; Substance-Related Disorders; tat Gene Products, Human Immunodeficiency Virus; Up-Regulation; Virus Replication | 2012 |
Methamphetamine-associated acute myocardial infarction and cardiogenic shock with normal coronary arteries: refractory global coronary microvascular spasm.
Topics: Adult; Amphetamine-Related Disorders; Central Nervous System Stimulants; Coronary Angiography; Coronary Vasospasm; Disease Progression; Electrocardiography; Humans; Male; Methamphetamine; Myocardial Infarction; Shock, Cardiogenic | 2007 |
1 trial(s) available for methamphetamine and Disease Exacerbation
| Article | Year |
|---|---|
Recent stimulant use and leukocyte gene expression in methamphetamine users with treated HIV infection.
Topics: Adult; Cocaine; Disease Progression; Gene Expression; HIV; HIV Infections; HIV Seropositivity; Humans; Interleukin-6; Leukocytes; Male; Methamphetamine; Middle Aged; Sequence Analysis, RNA; Tumor Necrosis Factor-alpha; Viral Load | 2018 |
16 other study(ies) available for methamphetamine and Disease Exacerbation
| Article | Year |
|---|---|
Chalky adrenals: a sequelae of antiphospholipid syndrome.
Topics: Adrenal Glands; Antiphospholipid Syndrome; Calcium Carbonate; Disease Progression; Humans; Methamphetamine | 2022 |
Methamphetamine (
Topics: Acidosis; Adult; Disease Progression; Humans; Hypertension; Kidney Failure, Chronic; Male; Methamphetamine; Substance Abuse, Intravenous; Substance Abuse, Oral | 2019 |
Clinical and echocardiographic outcomes in heart failure associated with methamphetamine use and cessation.
Topics: Adrenergic Uptake Inhibitors; Diastole; Disease Progression; Echocardiography; Female; Follow-Up Studies; Heart Failure; Heart Ventricles; Humans; Male; Methamphetamine; Middle Aged; Prognosis; Retrospective Studies; Stroke Volume; Systole; Ventricular Function, Left; Withholding Treatment | 2021 |
Substance-associated elevations in monocyte activation among methamphetamine users with treated HIV infection.
Topics: Adult; CD4 Lymphocyte Count; Central Nervous System Stimulants; Cocaine; Cross-Sectional Studies; Disease Progression; HIV Infections; Humans; Interleukin-6; Male; Methamphetamine; Middle Aged; Monocytes; Randomized Controlled Trials as Topic; Substance-Related Disorders; Young Adult | 2018 |
Psychosocial Correlates of Monocyte Activation and HIV Persistence in Methamphetamine Users.
Topics: Adult; Amphetamine-Related Disorders; Central Nervous System Stimulants; Cross-Sectional Studies; Disease Progression; HIV Infections; HIV-1; Humans; Lipopolysaccharide Receptors; Male; Methamphetamine; Middle Aged; Monocytes; Psychology; Viral Load; Virus Latency | 2019 |
The time course of blood brain barrier leakage and its implications on the progression of methamphetamine-induced seizures.
Topics: Animals; Blood-Brain Barrier; Capillary Permeability; Central Nervous System Stimulants; Disease Progression; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Seizures; Time Factors | 2018 |
Expansive pulmonary artery aneurysm in an IV drug user.
Topics: Aneurysm; Disease Progression; Dyspnea; Fatal Outcome; Heroin; Humans; Male; Methamphetamine; Middle Aged; Pulmonary Artery; Radiography; Substance Abuse, Intravenous | 2015 |
From initiating injecting drug use to regular injecting: Retrospective survival analysis of injecting progression within a sample of people who inject drugs regularly.
Topics: Adolescent; Adult; Child; Cohort Studies; Cross-Sectional Studies; Disease Progression; Female; Heroin; Heroin Dependence; Humans; Male; Methamphetamine; Retrospective Studies; Substance Abuse, Intravenous; Survival Analysis; Young Adult | 2016 |
Methamphetamine-Associated Congestive Heart Failure: Increasing Prevalence and Relationship of Clinical Outcomes to Continued Use or Abstinence.
Topics: Adult; Aged; Amphetamine-Related Disorders; California; Central Nervous System Stimulants; Disease Progression; Female; Heart Failure; Humans; Male; Methamphetamine; Middle Aged; Patient Admission; Prevalence; Recovery of Function; Retrospective Studies; Risk Factors; Stroke Volume; Time Factors; Treatment Outcome | 2016 |
Progressive gene dose-dependent disruption of the methamphetamine-sensitive circadian oscillator-driven rhythms in a knock-in mouse model of Huntington's disease.
Topics: Age Factors; Animals; Central Nervous System Stimulants; Chronobiology Disorders; Circadian Rhythm; Disease Models, Animal; Disease Progression; Dose-Response Relationship, Drug; Humans; Huntingtin Protein; Huntington Disease; Methamphetamine; Mice; Mice, Inbred C57BL; Mice, Transgenic; Motor Activity; Mutation | 2016 |
Methamphetamine enhances histoplasmosis by immunosuppression of the host.
Topics: Animals; Antigens, Fungal; Disease Progression; Female; Histoplasma; Histoplasmosis; Humans; Immunosuppression Therapy; Interferon-gamma; Interleukin-10; Interleukin-12; Lung; Methamphetamine; Mice; Mice, Inbred C57BL; Substance-Related Disorders; Tumor Necrosis Factor-alpha | 2009 |
Anti-(+)-methamphetamine monoclonal antibody antagonists designed to prevent the progression of human diseases of addiction.
Topics: Amphetamine-Related Disorders; Animals; Antibodies, Monoclonal; Delayed-Action Preparations; Disease Progression; Drug Delivery Systems; Humans; Methamphetamine; Secondary Prevention | 2010 |
Microglial activation precedes dopamine terminal pathology in methamphetamine-induced neurotoxicity.
Topics: Animals; Axons; Brain; Cell Count; Cell Size; Corpus Striatum; Disease Progression; Dopamine; Hypothermia, Induced; Male; Methamphetamine; Microglia; Neurotoxicity Syndromes; Rats; Rats, Sprague-Dawley | 2004 |
Cocaine and methamphetamine: differential addiction rates.
Topics: Adult; Amphetamine-Related Disorders; California; Cocaine-Related Disorders; Disease Progression; Female; Humans; Likelihood Functions; Logistic Models; Male; Methamphetamine; Risk Factors; Time Factors | 2000 |
Acceleration of HIV dementia with methamphetamine and cocaine.
Topics: Adult; AIDS Dementia Complex; Amphetamine-Related Disorders; Antiretroviral Therapy, Highly Active; Blood-Brain Barrier; Brain; Cholinergic Antagonists; Cocaine-Related Disorders; Disease Progression; Humans; Levodopa; Magnetic Resonance Imaging; Male; Methamphetamine; Movement Disorders | 2001 |
The role of dopamine in motor symptoms in the R6/2 transgenic mouse model of Huntington's disease.
Topics: Aging; Animals; Behavior, Animal; Brain; Brain Chemistry; Central Nervous System Stimulants; Cocaine; Diabetes Complications; Diabetes Mellitus; Disease Models, Animal; Disease Progression; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Female; Glucose Tolerance Test; Huntington Disease; Levodopa; Methamphetamine; Mice; Mice, Inbred C57BL; Mice, Transgenic; Motor Activity; Spatial Behavior; Survival Rate | 2002 |